Skip to content

TENAX THERAPEUTICS, INC.: 10-Q filed 2018-08-14

What TENAX THERAPEUTICS, INC. reported in its quarterly report filed 2018-08-14 (fiscal Q2 2018): 29 published measures, 76 facts as tagged in accession 0001654954-18-009137.

This filing

Form
10-Q (quarterly report)
Filed
2018-08-14
Fiscal period
fiscal Q2 2018
Accession
0001654954-18-009137 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All TENAX THERAPEUTICS, INC. filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

PeriodValueUnitDays
At 2018-06-307,025,827USD
At 2017-12-319,890,701USD

Total liabilities

Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.

PeriodValueUnitDays
At 2018-06-30792,791USD
At 2017-12-311,008,840USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

PeriodValueUnitDays
At 2018-06-306,233,036USD
At 2017-12-318,881,861USD

Cash and cash equivalents

Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.

PeriodValueUnitDays
At 2018-06-303,902,878USD
At 2017-12-311,604,810USD
At 2017-06-302,233,686USD
At 2016-12-319,995,955USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

PeriodValueUnitDays
2018-04-01 to 2018-06-301,871,415USD91
2018-01-01 to 2018-06-303,051,408USD181
2017-04-01 to 2017-06-302,986,170USD91
2017-01-01 to 2017-06-306,261,755USD181

Operating cash flow

Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.

PeriodValueUnitDays
2018-01-01 to 2018-06-30-2,746,125USD181
2017-01-01 to 2017-06-30-9,632,514USD181

Capital expenditure payments

Cash payments to acquire property, plant and equipment. This taxonomy concept does not capture every form of investment or acquisition.

PeriodValueUnitDays
2018-01-01 to 2018-06-305,807USD181
2017-01-01 to 2017-06-303,272USD181

Investing cash flow

Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.

PeriodValueUnitDays
2018-01-01 to 2018-06-305,044,193USD181
2017-01-01 to 2017-06-301,870,245USD181

Retained earnings or deficit

Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.

PeriodValueUnitDays
At 2018-06-30-216,550,693USD
At 2017-12-31-213,499,285USD

Net property, plant and equipment

Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.

PeriodValueUnitDays
At 2018-06-3010,310USD
At 2017-12-319,945USD

Share-based compensation expense

Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.

PeriodValueUnitDays
2018-01-01 to 2018-06-30263,861USD181
2017-01-01 to 2017-06-3079,525USD181

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

PeriodValueUnitDays
2018-04-01 to 2018-06-301,888,875USD91
2018-01-01 to 2018-06-303,111,929USD181
2017-04-01 to 2017-06-303,014,369USD91
2017-01-01 to 2017-06-306,513,255USD181

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

PeriodValueUnitDays
At 2018-06-306,709,704USD
At 2017-12-318,062,893USD

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

PeriodValueUnitDays
At 2018-06-30792,791USD
At 2017-12-311,008,840USD

Current accounts payable

Current amounts owed to suppliers for goods and services received. This is one component of current liabilities, not all accrued obligations.

PeriodValueUnitDays
At 2018-06-30203,153USD
At 2017-12-31611,861USD

Net current accounts receivable

Current customer receivables after the allowance for credit loss. The balance is not cash collected or a guarantee of collection.

PeriodValueUnitDays
At 2018-06-3039,286USD
At 2017-12-3150,171USD

Operating expenses

Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.

PeriodValueUnitDays
2018-04-01 to 2018-06-30-1,888,875USD91
2018-01-01 to 2018-06-30-3,111,929USD181
2017-04-01 to 2017-06-30-3,014,369USD91
2017-01-01 to 2017-06-30-6,513,255USD181

Selling, general and administrative expense

Selling and general administrative costs reported under this concept. It is an expense category, not a substitute for total operating expenses.

PeriodValueUnitDays
2018-04-01 to 2018-06-30-1,577,724USD91
2018-01-01 to 2018-06-30-2,742,191USD181
2017-04-01 to 2017-06-30-1,791,436USD91
2017-01-01 to 2017-06-30-3,238,890USD181

Research and development expense

Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.

PeriodValueUnitDays
2018-04-01 to 2018-06-30-311,151USD91
2018-01-01 to 2018-06-30-369,738USD181
2017-04-01 to 2017-06-30-1,222,933USD91
2017-01-01 to 2017-06-30-3,274,365USD181

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

PeriodValueUnitDays
At 2018-06-301,453,676shares
At 2017-12-311,411,840shares

Accumulated other comprehensive income or loss

Cumulative other comprehensive items after tax, such as translation and unrealized hedging or securities effects. These amounts have not passed through net income.

PeriodValueUnitDays
At 2018-06-30-16,495USD
At 2017-12-31-16,193USD

Gross property, plant and equipment

Cost of property, plant and equipment before accumulated depreciation. Historical cost does not indicate current value or replacement cost.

PeriodValueUnitDays
At 2018-06-30579,857USD
At 2017-12-31574,051USD

Accumulated depreciation on property, plant and equipment

Cumulative depreciation, depletion and amortization recorded against property, plant and equipment. It measures cost allocation to date, not physical wear or market value.

PeriodValueUnitDays
At 2018-06-30569,547USD
At 2017-12-31564,106USD

Other noncurrent assets

Noncurrent assets the filer does not present separately. The composition differs by filer and is described only in the filing.

PeriodValueUnitDays
At 2018-06-308,435USD
At 2017-12-318,435USD

Accrued current liabilities

Current obligations accrued for goods and services received but not yet invoiced or paid. This is one component of current liabilities, not all short-term obligations.

PeriodValueUnitDays
At 2018-06-30565,087USD
At 2017-12-31363,306USD

Profit or loss including noncontrolling interests

Net income or loss including the portion attributable to noncontrolling interests. It can differ from the net income attributable to the parent that per-share figures use.

PeriodValueUnitDays
2018-01-01 to 2018-06-303,051,408USD181
2017-01-01 to 2017-06-306,261,755USD181

Comprehensive income or loss

Net income plus other comprehensive income after tax. It includes unrealized items that net income excludes and is not a cash measure.

PeriodValueUnitDays
2018-04-01 to 2018-06-301,860,859USD91
2018-01-01 to 2018-06-303,051,710USD181
2017-04-01 to 2017-06-302,983,510USD91
2017-01-01 to 2017-06-306,252,552USD181

Depreciation expense

Depreciation recognized for the period under this concept. It is a noncash allocation of asset cost and may exclude amortization and depletion reported elsewhere.

PeriodValueUnitDays
2018-04-01 to 2018-06-303,000USD91
2018-01-01 to 2018-06-305,000USD181
2017-04-01 to 2017-06-303,000USD91
2017-01-01 to 2017-06-307,000USD181

Other nonoperating income or expense

Other income or expense outside operations under this concept. The composition is filer-specific and can include one-time items.

PeriodValueUnitDays
2018-04-01 to 2018-06-30-17,460USD91
2018-01-01 to 2018-06-30-60,521USD181
2017-04-01 to 2017-06-30-28,199USD91
2017-01-01 to 2017-06-30-251,500USD181

Inspect the source

Entity
TENAX THERAPEUTICS, INC. / CIK 0000034956
Captured
2026-09-19T14:46:45.117Z
SEC response SHA-256
3f4f90f5f823d316ffb20bc63506ae090888657f5ff1cb9568439e153f028cf5

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0000034956.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))